Veracyte Inc (VCYT)
Days of inventory on hand (DOH)
Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 6.26 | 6.39 | 7.18 | 7.21 | 7.15 | 7.02 | 7.35 | 6.95 | 9.40 | 7.82 | 7.11 | 7.08 | 6.39 | 6.93 | 6.63 | 6.38 | 7.71 | 6.60 | 8.90 | 9.06 | |
DOH | days | 58.31 | 57.16 | 50.82 | 50.61 | 51.08 | 51.99 | 49.65 | 52.54 | 38.84 | 46.65 | 51.36 | 51.58 | 57.14 | 52.69 | 55.07 | 57.18 | 47.36 | 55.33 | 41.00 | 40.27 |
June 30, 2025 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 6.26
= 58.31
The Days of Inventory on Hand (DOH) for Veracyte Inc. has demonstrated notable fluctuations from September 2020 through June 2025. In September 2020, the DOH was approximately 40.27 days, indicating a relatively efficient inventory management period at that time. Over the next few quarters, the DOH gradually increased, reaching approximately 57.18 days by September 2021, reflecting a lengthening of inventory turnover periods and possibly indicating slower inventory movement or increased inventory levels.
Between December 2021 and September 2022, the DOH fluctuated within a range of approximately 51.36 to 55.07 days, suggesting some stabilization but with ongoing variability. A decreasing trend was observed in the first half of 2023, with the figure dropping to around 38.84 days by June 2023, which could signal improved inventory management or faster inventory turnover during that period.
Subsequently, the DOH increased again, reaching approximately 52.54 days as of September 2023, indicating a possible shift in inventory practices or changes in product demand. This upward trend persisted slightly into December 2023 at 49.65 days, with a marginal decrease in March 2024 to approximately 51.99 days, and then a slight stabilization around 50.61 to 51.08 days in mid-2024.
In the most recent data, extending to June 2025, the DOH shows an increasing pattern again, with figures around 57.16 days in March 2025 and rising to approximately 58.31 days by June 2025. This upward movement suggests a lengthening of inventory holding periods, potentially attributable to strategic inventory buildup, slower sales cycles, or other operational factors.
Overall, the DOH for Veracyte Inc. has experienced periods of both increase and decrease, with a general trend toward longer inventory durations in the later years, particularly from mid-2024 onward. These shifts may reflect changes in sales efficiency, inventory management strategies, or product demand dynamics over the analyzed period.
Peer comparison
Jun 30, 2025